Intrapartum fetal distress and magnesium sulfate

International Journal of Gynecology and Obstetrics

Volumn 68, Issue 1, 2000, Pages 3-6

  Vigil De Gracia, P ^a   Simiti E ^a   Lora, Y ^a  

^a Complejo Hospitalario Metropolitano de la Caja de Seguro Social ^*  (Panama)

Author keywords

Intrapartum fetal distress; Magnesium sulfate; Tocolysis

Indexed keywords

MAGNESIUM SULFATE; OXYTOCIN;

ADULT; APGAR SCORE; ARTICLE; CESAREAN SECTION; CHILDBIRTH; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FETUS; FETUS DISTRESS; FETUS HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; TOCOLYSIS; UTERUS CONTRACTION;

ANTI-ARRHYTHMIA AGENTS; FEMALE; FETAL DISTRESS; HEART RATE, FETAL; HUMANS; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; TOCOLYTIC AGENTS; TREATMENT OUTCOME;

EID: 0033991845     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(99)00163-0     Document Type: Article

References (20)

1. Patriarco MS, Viechnicki BM, Hutchinson TA, Klasko SK, Yeh SY. A study on intrauterine fetal resuscitation with terbutaline. Am J Obstet Gynecol 1987;157: 384-387.
2. The Eclampsia Trial Collaborative Group. Which anticonvulsivant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 1995;345: 1455-1463.
3. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. New Engl J Med 1995;333:201-205.
4. Hatjes CG, Swain M, Nelson LH, Meis PJ, Ernest JM. Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor. Obstet Gynecol 1987;69:317-322.
5. Gordon MC, Iams JD. Magnesium sulfate. Clin Obstet Gynecol 1995;38:707-712.
6. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995;95:263-269.
7. Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. J Am Med Assoc 1996;276:1805-1810.
8. Reece EA, Chervenak FA, Romero R, Hobbins JC. Magnesium sulfate in the management of acute intrapartum fetal distress. Am J Obstet Gynecol 1984;148: 104-106.
9. Magan EF, Cleveland RS, Dockery JR, Chauhan SP, Martin JN, Morrison JC. Acute tocolysis for fetal distress: terbutaline versus magnesium sulfate. Aust NZ J Obstet Gynaecol 1993;33:362-364.
10. Petrikosvky BM, Vintzileos AM. Magnesium sulfate and intrapartum fetal behavior. Am J Perinatol 1990; 7:154-156.
11. Vigil-De Gracia P, Montufar C, Cubilla J, Robinson Vas A. Eficacia y seguridad del Sulfato de Magnesio y Nifedipina en el manejo de la amenaza de parto pretermino. Cienc Méd 1997;1:89-93.
12. Hollander DI, Nagey DA, Pupkin MJ. Magnesium sulfate and ritodrine hydrochloride: a randomized comparison. Am J Obstet Gynecol 1987;156:631-637.
13. Simchen MJ, Dulitzky M, Mashiach S, Friedman SA, Schiff E. Adjustment of magnesium sulfate infusion rate in patients with preterm labor. Am J Obstet Gynecol 1998;179:994-998.
14. Cox SM, Sherman ML, Leveno KJ. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 1990;163:767-772.
15. Higby K, Xenakis EMJ, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993;168:2147-2159.
16. Peaceman AM, Meyer BA, Thorp JA, Parisi VM, Creasy RK. The effect of magnesium sulfate tocolysis on fetal biophysical profile. Am J Obstet Gynecol 1989;161: 771-774.
17. Canez MS, Reed KL, Shenker L. Effect of maternal magnesium sulfate treatment on fetal heart variability. Am J Perinatol 1987;4:167-170.
18. Gray SE, Rodis JF, Lettieri L, Egan JFX, Vintzileos A. Effect of intravenous magnesium sulfate on the biophysical profile of the healthy preterm fetus. Am J Obstet Gynecol 1994;170:1131-1135.
19. Mittendorf R, Covert R, Boman J, Khoshnood B, Lee K-S, Siegler M. Is tocolytic magnesium sulfate associated with increased total paediatric mortality? Lancet 1997;350:1517-1518.
20. Correspondence. Tocolytic magnesium sulphate and paediatric mortality. Lancet 1998;351:290-293.